March 28, 2006Current Pharmaceutical Design
Biology and Pharmacology of the Platelet P2Y12 Receptor
Key result
The platelet P2Y12 receptor plays a critical role in amplifying platelet activation and arterial thrombosis, making it an ideal target for pharmacological inhibition with agents like clopidogrel.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
P2Y12's Gi-linked amplification role prioritizes it for inhibition; leaves open optimal selective strategies in practice.
Key Points
- To explore the biology and pharmacology of the P2Y12 receptor and its role in platelet activation and thrombosis.
- Descriptive analysis of platelet receptors P2Y1 and P2Y12 and their signaling pathways.
- Discussion of pharmacological implications of P2Y12 receptor antagonists like clopidogrel.
- P2Y12 receptor activation amplifies platelet responses essential for arterial thrombosis and inflammation.
- Clopidogrel demonstrates efficacy in blocking P2Y12, but therapy shows variability in receptor blockade.
- Enhanced strategies for P2Y12 receptor inhibition could lead to improved clinical outcomes.
PICO
P
Population
Arterial thrombosis
I
Intervention / Comparator
P2Y12 receptor antagonists
The P2Y12 receptor plays a critical role in amplifying platelet activation, making it a key pharmacological target for preventing arterial thrombosis, with room for improvement over existing therapies like clopidogrel.
Cite This Study
Robert F. Storey (2006) conducted a review in Arterial thrombosis. P2Y12 receptor antagonists was evaluated. The platelet P2Y12 receptor plays a critical role in amplifying platelet activation and arterial thrombosis, making it an ideal target for pharmacological inhibition with agents like clopidogrel.